U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07019909) titled 'A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese Adults' on June 05.
Brief Summary: This Phase 1, randomized, double-blind, third-party-unblinded study will be conducted at investigational sites in China. The purpose of the study is to learn about the safety and immune response of 20vPnC and 13vPnC in Chinese adults 50 years of age and older who did not receive any of pneumococcal vaccine in the past
Study Start Date: July 14
Study Type: INTERVENTIONAL
Condition:
Pneumococcal Disease
Intervention:
BIOLOGICAL: 20vPnC
20 valent pneumococcal conjugate vaccine
BIOLOGICAL: 13vPnC
13 valent p...